Broad, AstraZeneca Target Antibiotics | Chemical & Engineering News
Volume 90 Issue 38 | p. 17 | Concentrates
Issue Date: September 17, 2012

Broad, AstraZeneca Target Antibiotics

Department: Business
Keywords: antibiotics, pharmaceuticals, industry-academia collaborations

AstraZeneca and the Broad Institute will work together to find new antibacterial and antiviral compounds. Under the two-year pact, Broad will screen its custom-made chemical library of 100,000 molecules generated by diversity-oriented synthesis. AstraZeneca will be responsible for optimizing and developing any lead compounds discovered by Broad. In the past 30 years, just two new classes of antibiotics have emerged, despite an alarming rise in drug-resistant bacteria, AstraZeneca notes.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment